CLASS II Drug recall · Reported 24 Jun 2020 · FDA Enforcement Report

Gaviscon Extra Strength Liquid Antacid Extra Strength Cherry recalled

Glaxosmithkline Consumer Healthcare Holdings is recalling Gaviscon Extra Strength Liquid Antacid Extra Strength Cherry, distributed nationwide in the US. The recall was initiated on 28 May 2020 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesLot #: 0A26C1, Exp 12/31/2021; 0B10C1, Exp 1/31/2022; 8L19C1, Exp 10/31/2020; 8L27C1, Exp 10/31/2020; 9A28C1, Exp 12/31/2020; 9B18C1, Exp 1/31/2021; 9C19C1, Exp 2/28/2021; 9D09C1, Exp 3/31/2021; 9F20C1, Exp 5/31/2021; 9G24C1, Exp 6/30/2021; 9J09C1, Exp 8/31/2021; 9K29C1, Exp 9/30/2021; 9L05C1, Exp 9/30/2021

Quantity recalled629,796 bottles

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

Recall details

Recall number: D-1324-2020
FDA event ID: 85755
Recalling firm: Glaxosmithkline Consumer Healthcare Holdings, Warren, NJ
Classification: Class II
Status: Terminated
Recall initiated: 28 May 2020
FDA classified: 18 Jun 2020
Reported: 24 Jun 2020
Type: Voluntary: Firm initiated
Customers notified by: Letter
Reason category: Other Reasons

Timeline

28 May 2020	Recall initiated by company
18 Jun 2020	Classified by FDA	+21 days
24 Jun 2020	Published in enforcement report	+6 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Labeling: Label lacks warning - Magnesium safety warning is not present on the Gaviscon bottle label.

Product as listed by the FDA

Gaviscon Extra Strength Liquid Antacid Extra Strength Cherry, 12 FL OZ. (355 mL), Distributed by: GSK Consumer Healthcare Warren, NJ 07059, NDC 0135-0574-41

Where it was distributed

U.S.A. Nationwide

Nationwide

Questions about this recall

Why was it recalled?

Labeling: Label lacks warning - Magnesium safety warning is not present on the Gaviscon bottle label.

Which lots are affected?

Lot #: 0A26C1, Exp 12/31/2021; 0B10C1, Exp 1/31/2022; 8L19C1, Exp 10/31/2020; 8L27C1, Exp 10/31/2020; 9A28C1, Exp 12/31/2020; 9B18C1, Exp 1/31/2021; 9C19C1, Exp 2/28/2021; 9D09C1, Exp 3/31/2021; 9F20C1, Exp 5/31/2021; 9G24C1, Exp 6/30/2021; 9J09C1, Exp 8/31/2021; 9K29C1, Exp 9/30/2021; 9L05C1, Exp 9/30/2021

Where was it sold?

U.S.A. Nationwide

What should I do if I have it?

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

Other products in this recall event

3 other products · FDA event 85755

This product is part of a recall event; the main page for the event is Gaviscon Regular Strength Liquid Antacid Cool Mint recalled.

Reported	Class	Recall	Company	Reason	Where
24 Jun 2020	CLASS II	Gaviscon Regular Strength Liquid Antacid Cool Mint recalledGaviscon	Glaxosmithkline Consumer Healthcare Holdings	Other	Nationwide
24 Jun 2020	CLASS II	Gaviscon Liquid Antacid Extra Strength recalledGaviscon	Glaxosmithkline Consumer Healthcare Holdings	Other	Nationwide
24 Jun 2020	CLASS II	Gaviscon Regular Strength Liquid Antacid Cool Mint recalledGaviscon	Glaxosmithkline Consumer Healthcare Holdings	Other	Nationwide

More recalls from Glaxosmithkline Consumer Healthcare Holdings

All 26

Reported	Class	Recall	Company	Reason	Where
8 Nov 2023Drug	CLASS II	TUMS Antacid, Calcium Carbonate USP 1000 mg recalled	GlaxoSmithKline Consumer Healthcare Holdings	Foreign Material	Nationwide
8 Nov 2023Drug	CLASS II	TUMS Antacid, Calcium Carbonate USP 1000 mg recalled	GlaxoSmithKline Consumer Healthcare Holdings	Foreign Material	Nationwide
8 Nov 2023Drug	CLASS II	TUMS Antacid, Calcium Carbonate USP 1000 mg recalledTums	GlaxoSmithKline Consumer Healthcare Holdings	Foreign Material	Nationwide
8 Nov 2023Drug	CLASS II	TUMS Antacid, Calcium Carbonate USP 1000 mg recalledTums	GlaxoSmithKline Consumer Healthcare Holdings	Foreign Material	Nationwide
8 Nov 2023Drug	CLASS II	TUMS Antacid, Calcium Carbonate USP 1000 mg recalledTums	GlaxoSmithKline Consumer Healthcare Holdings	Foreign Material	Nationwide